Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study
Crossref DOI link: https://doi.org/10.1186/s12883-017-0952-9
Published Online: 2017-09-04
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zecca, Chiara
Disanto, Giulio
Mühl, Sarah
Gobbi, Claudio
Funding for this research was provided by:
Merck KGaA
